Zhejiang Tailin BioEngineering Co.,Ltd (SHE:300813)

Market Cap	3.08B +29.2%
Revenue (ttm)	339.54M -2.7%
Net Income	16.49M +26.3%
EPS	0.14 +16.7%
Shares Out	121.20M
PE Ratio	181.64
Forward PE	n/a
Dividend	0.03 (0.12%)
Ex-Dividend Date	May 6, 2026

Volume	1,978,330
Average Volume	4,570,087
Open	24.70
Previous Close	25.43
Day's Range	24.70 - 26.00
52-Week Range	16.53 - 42.25
Beta	1.21
RSI	42.10
Earnings Date	Apr 30, 2026

About SHE:300813

Zhejiang Tailin BioEngineering Co.,Ltd research and development, production, and sells microbial detection, contamination control, process analysis, and inhibition protection in the life sciences field in China and internationally. It primarily provides aseptic production and contamination control equipment, microbial testing products, and organic matter analysis technology products. The company also offers pharma processing, such as pharma isolator, high precision filling and dispensing, sterile transfer; cell and gene therapy; radiopharma; la...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1993
• Employees: 790
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300813

Financial Performance

In 2025, SHE:300813's revenue was 339.54 million, a decrease of -2.71% compared to the previous year's 349.00 million. Earnings were 16.49 million, an increase of 26.32%.